Healthtech Startups

4D Healthware offers Virtual CCM, a technology platform for chronic care management that lets healthcare providers deliver care beyond the clinic in settings such as homes, pharmacies, grocery stores, workplaces, and online. It is aimed at healthcare providers seeking to extend patient care outside traditional clinical settings.

2 investors

4G Clinical builds technology and delivery services aimed at reducing avoidable delay in clinical trial execution, serving sponsors, CROs, and research sites. The company works within the clinical research and clinical trial supply space to help therapies reach patients faster.

2 investors

4TEEN4 develops monoclonal antibody therapeutics targeting shock and critical illness in patients. The company is advancing invobenitug (procizumab), a first-in-class treatment designed to address circulating dipeptidyl peptidase 3, a molecular driver of cardiovascular dysfunction and organ failure in shock states.

2 investors

5AM Ventures is an investment firm with professionals holding expertise in science, medicine, operations, legal, and finance who identify and develop life science portfolio companies.

2 investors

6Degrees is an Israel-based startup that develops digital accessibility solutions to help people with physical challenges gain independence, improve communication, and increase employability through enhanced digital access.

2 investors

7D Surgical develops image-guided surgical navigation systems using machine-vision technology for spine, cranial, and percutaneous procedures. The company's FLASH Navigation Platform and FLASH EVD system assist surgeons in achieving precision during operating room and bedside interventions.

2 investors

EightMedical provides on-demand ambulance and urgent medical care services, including emergency response, ambulance standby for events, ambulance transport, and urgent care. It serves individuals, event planners, hospitals, estates, schools, production companies, and HMOs in Nigeria.

2 investors

98point6 Technologies builds and licenses text-based virtual care software to healthcare organizations, with integrations for electronic health records, clinical documentation, and provider decision-support tools. The company serves healthcare providers seeking to expand access to care, improve patient engagement, and reduce costs.

2 investors

A Place for Mom is a senior care referral service that helps families find and compare senior living and care options, including assisted living, memory care, independent living, home care, nursing homes, and senior apartments. It also provides guides and resources such as VA benefits information for long-term care.

2 investors

A10 Lab Inc. develops みんチャレ (Minna Challenge), a behavioral change platform that leverages community support and technology to help users achieve health and wellness goals, particularly targeting lifestyle disease prevention and frailty prevention through mobile and business solutions.

2 investors

AADAR produces Ayurvedic herbal wellness supplements designed for men to enhance stamina, energy, and sexual performance. The company formulates natural supplements using traditional Ayurvedic ingredients such as Safed Musli, Ashwagandha, and Shilajit.

2 investors

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.

2 investors

Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

2 investors

Abi Global Health provides a virtual care platform combining AI and licensed healthcare professionals to deliver on-demand medical consultations across 40+ countries in 25+ languages. The platform serves insurers, employers, health systems, and governments seeking to expand healthcare access and reduce costs.

2 investors

Abingdon Health is a contract developer and manufacturer of rapid lateral flow diagnostic tests, serving healthcare, animal health, and plant health sectors. It provides services from biomarker validation through FDA submission, scale-up, and large-scale manufacturing, and also supplies its own lateral flow test brands to consumers, retail, wholesale, and distributors globally.

2 investors

Able Human Motion develops a lightweight, quick-to-fit exoskeleton for neurorehabilitation in clinical settings, actively assisting people with mobility impairments to walk again. It targets neurorehabilitation clinics and patients with neurological disabilities, and has been validated in hospitals across Germany, the Netherlands, the UK, and Spain.

2 investors

Able Innovations builds the ALTA Platform, a patient-handling system that lets a single user transfer patients at the push of a button to reduce physical strain and protect patient skin and tissue. It targets healthcare providers and professionals involved in patient transfer and handling.

2 investors

AbsoluteCare provides whole-person, integrated primary and behavioral health care for vulnerable, chronically ill members through comprehensive care centers, community outreach, and in-home visits. Its care model addresses social drivers of health such as housing, transportation, and food security alongside medical needs.

2 investors

Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications. The company designs and manufactures its medical devices for clinical use in the United States.

2 investors

Accountable provides a platform that automates HIPAA compliance tasks including policies, training, risk assessments, vendor management, and incident tracking for small and mid-size healthcare organizations such as dental offices, therapy practices, and health tech startups.

2 investors

Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.

2 investors

Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits. The technology is aimed at human therapeutics for genetic diseases and is offered for licensing.

2 investors

ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.

2 investors

Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.

2 investors